Stocksigma LogoStocksigma Logo

Bio Medica Laboratories Board to Consider H1 FY27 Financial Results

Bio Medica Laboratories Ltd. announced that its Board of Directors will meet on 5th Nov'26 to consider and approve the unaudited standalone and

Bio Medica Laboratories Board to Consider H1 FY27 Financial Results

Bio Medica Laboratories Ltd 路 Intimation 路 05 Nov 2026, 5:30 am

Bio Medica Laboratories Board to Consider H1 FY27 Financial Results Bio Medica Laboratories Ltd. announced that its Board of Directors will meet on 5th Nov'26 to consider and approve the unaudited standalone and consolidated financial results, along with the Limited Review Report, for the half year ended 30th Sep'26. Additionally, the company confirmed that the trading window for dealing in its securities has been closed for designated persons from 1st Oct'26 and will reopen 48 hours after the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Bio Medica Laboratories Ltd

All Bio Medica Laboratories Ltd announcements